Evolva Holding S.A. (ELVAF)
ELVAF Stock Price Chart
Explore Evolva Holding S.A. interactive price chart. Choose custom timeframes to analyze ELVAF price movements and trends.
ELVAF Company Profile
Discover essential business fundamentals and corporate details for Evolva Holding S.A. (ELVAF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
8 Jan 2021
Employees
49.00
Website
https://www.evolva.comCEO
Gerhard Lobmaier
Description
Evolva Holding SA discovers, researches, develops, and commercializes nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. It offers various ingredients comprising Veri-te Resveratrol, a nature-made polyphenol that occurs naturally in grapes and other plants, including peanuts, cranberries, and berries; L-Arabinose, a flavoring agent used in Maillard reaction; Valencene, an aroma component of citrus fruit and citrus-derived odorants; Nootkatone, an aroma ingredient of grapefruit obtained via biochemical oxidation of valencene; and Vanillin, a primary component of vanilla bean extract. The company was founded in 2004 and is headquartered in Reinach, Switzerland.
ELVAF Financial Timeline
Browse a chronological timeline of Evolva Holding S.A. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 19 Feb 2026
Upcoming earnings on 27 Oct 2025
Earnings released on 21 Feb 2025
EPS came in at -$0.08 .
Earnings released on 21 Oct 2024
EPS came in at $0.21 .
Earnings released on 12 Apr 2024
EPS came in at -$2.55 , while revenue for the quarter reached -$345.93K , missing expectations by -102.21%.
Earnings released on 30 Jun 2023
EPS came in at -$19.62 , while revenue for the quarter reached $4.96M , missing expectations by -28.29%.
Stock split effective on 10 May 2023
Shares were split 1 : 250 , changing the number of shares outstanding and the price per share accordingly.
Stock split effective on 26 Apr 2023
Shares were split 1 : 250 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 31 Dec 2022
EPS came in at -$3.51 , while revenue for the quarter reached $8.01M , beating expectations by +2.83%.
Earnings released on 30 Jun 2022
EPS came in at -$6.84 , while revenue for the quarter reached $8.49M .
Earnings released on 31 Dec 2021
EPS came in at -$4.60 , while revenue for the quarter reached $3.83M , missing expectations by -58.41%.
Earnings released on 30 Jun 2021
EPS came in at -$8.14 , while revenue for the quarter reached $6.90M , beating expectations by +22.69%.
Earnings released on 31 Dec 2020
EPS came in at -$5.83 falling short of the estimated -$5.66 by -2.99%, while revenue for the quarter reached $4.05M , missing expectations by -0.66%.
ELVAF Stock Performance
Access detailed ELVAF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.